Cargando…
SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma
Liver Hepatocellular Carcinoma (LIHC) is the fifth widely occurred carcinoma, which is thought to be the second primary contributor of carcinoma-associated death. There are almost 788,000 death tolls worldwide. Solute carrier family 41 member 3 (SLC41A3) is a member of solute carrier family 41, and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608493/ https://www.ncbi.nlm.nih.gov/pubmed/34819993 http://dx.doi.org/10.1155/2021/8556888 |
_version_ | 1784602750860918784 |
---|---|
author | Chang, Qimeng Xu, Yayun Wang, Jianfa Jing, Hui Rao, Longhua Tang, Weiguo Zhang, Ziping Wu, Xubo |
author_facet | Chang, Qimeng Xu, Yayun Wang, Jianfa Jing, Hui Rao, Longhua Tang, Weiguo Zhang, Ziping Wu, Xubo |
author_sort | Chang, Qimeng |
collection | PubMed |
description | Liver Hepatocellular Carcinoma (LIHC) is the fifth widely occurred carcinoma, which is thought to be the second primary contributor of carcinoma-associated death. There are almost 788,000 death tolls worldwide. Solute carrier family 41 member 3 (SLC41A3) is a member of solute carrier family 41, and it is the key point of numerous researches. Our research attempted to explore the links between SLC41A3 and LIHC through public databases. Higher expression of SLC41A3 displayed an intimate association with higher pathological stages and poorer prognosis. GO and KEGG analysis revealed the possible regulatory pathways of SLC41A3. Additionally, we carried out cell functional experiments to determine the expression of SLC41A3 in the cell lines of LIHC, as well as the effects of its silence on cell proliferation, migration, and invasion. Our data showed that SLC41A3 was greatly increased in the cell lines of LIHC. Moreover, silencing SLC41A3 impeded LIHC cell proliferation, migration, and invasion in vitro. Collectively, our study demonstrated that highly expressed SLC41A3 was a probable indication of LIHC occurrence, and SLC41A3 could be regarded as a prospective target in the treatment of LIHC. |
format | Online Article Text |
id | pubmed-8608493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-86084932021-11-23 SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma Chang, Qimeng Xu, Yayun Wang, Jianfa Jing, Hui Rao, Longhua Tang, Weiguo Zhang, Ziping Wu, Xubo Comput Math Methods Med Research Article Liver Hepatocellular Carcinoma (LIHC) is the fifth widely occurred carcinoma, which is thought to be the second primary contributor of carcinoma-associated death. There are almost 788,000 death tolls worldwide. Solute carrier family 41 member 3 (SLC41A3) is a member of solute carrier family 41, and it is the key point of numerous researches. Our research attempted to explore the links between SLC41A3 and LIHC through public databases. Higher expression of SLC41A3 displayed an intimate association with higher pathological stages and poorer prognosis. GO and KEGG analysis revealed the possible regulatory pathways of SLC41A3. Additionally, we carried out cell functional experiments to determine the expression of SLC41A3 in the cell lines of LIHC, as well as the effects of its silence on cell proliferation, migration, and invasion. Our data showed that SLC41A3 was greatly increased in the cell lines of LIHC. Moreover, silencing SLC41A3 impeded LIHC cell proliferation, migration, and invasion in vitro. Collectively, our study demonstrated that highly expressed SLC41A3 was a probable indication of LIHC occurrence, and SLC41A3 could be regarded as a prospective target in the treatment of LIHC. Hindawi 2021-11-15 /pmc/articles/PMC8608493/ /pubmed/34819993 http://dx.doi.org/10.1155/2021/8556888 Text en Copyright © 2021 Qimeng Chang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Chang, Qimeng Xu, Yayun Wang, Jianfa Jing, Hui Rao, Longhua Tang, Weiguo Zhang, Ziping Wu, Xubo SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma |
title | SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma |
title_full | SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma |
title_fullStr | SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma |
title_full_unstemmed | SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma |
title_short | SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma |
title_sort | slc41a3 exhibits as a carcinoma biomarker and promoter in liver hepatocellular carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608493/ https://www.ncbi.nlm.nih.gov/pubmed/34819993 http://dx.doi.org/10.1155/2021/8556888 |
work_keys_str_mv | AT changqimeng slc41a3exhibitsasacarcinomabiomarkerandpromoterinliverhepatocellularcarcinoma AT xuyayun slc41a3exhibitsasacarcinomabiomarkerandpromoterinliverhepatocellularcarcinoma AT wangjianfa slc41a3exhibitsasacarcinomabiomarkerandpromoterinliverhepatocellularcarcinoma AT jinghui slc41a3exhibitsasacarcinomabiomarkerandpromoterinliverhepatocellularcarcinoma AT raolonghua slc41a3exhibitsasacarcinomabiomarkerandpromoterinliverhepatocellularcarcinoma AT tangweiguo slc41a3exhibitsasacarcinomabiomarkerandpromoterinliverhepatocellularcarcinoma AT zhangziping slc41a3exhibitsasacarcinomabiomarkerandpromoterinliverhepatocellularcarcinoma AT wuxubo slc41a3exhibitsasacarcinomabiomarkerandpromoterinliverhepatocellularcarcinoma |